Cargando…
Therapeutic Efficacy of Valproic Acid in a Combined Monocrotaline and Chronic Hypoxia Rat Model of Severe Pulmonary Hypertension
BACKGROUND: Pulmonary hypertension (PH) is a serious disease with poor prognosis. Reports show that cells in remodeled pulmonary arteries of PH patients have similar characteristics to cancer cells, such as exuberant inflammation, increased proliferation, and decreased apoptosis. An ideal strategy f...
Autores principales: | Lan, Beidi, Hayama, Emiko, Kawaguchi, Nanako, Furutani, Yoshiyuki, Nakanishi, Toshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309681/ https://www.ncbi.nlm.nih.gov/pubmed/25629315 http://dx.doi.org/10.1371/journal.pone.0117211 |
Ejemplares similares
-
Silibinin efficacy in a rat model of pulmonary arterial hypertension using monocrotaline and chronic hypoxia
por: Zhang, Tingting, et al.
Publicado: (2019) -
High expression of CXCR4 and stem cell markers in a monocrotaline and chronic hypoxia-induced rat model of pulmonary arterial hypertension
por: Zhang, Tingting, et al.
Publicado: (2018) -
Prospective In Vitro Models of Channelopathies and Cardiomyopathies
por: Kawaguchi, Nanako, et al.
Publicado: (2012) -
Silibinin Upregulates CXCR4 Expression in Cultured Bone Marrow Cells (BMCs) Especially in Pulmonary Arterial Hypertension Rat Model
por: Zhang, Tingting, et al.
Publicado: (2020) -
Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension
por: Kosanovic, Djuro, et al.
Publicado: (2011)